Jammu and Kashmir Bank Ltd
J&KBANKJammu and Kashmir Bank Ltd's price has outrun its earnings. +43.7% in a year against EPS +13.3% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +43.7% in a year while annual EPS moved +13.3% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (28 weeks in) while the P/BV sits at the 85th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −11.5% year on year, with the the net margin at 12.1%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Jammu and Kashmir Bank Ltd trades at ₹145, in a confirmed uptrend and 28 weeks into that stage. That is +5.7% against its own 200-day average. It sits at 50% of a 52-week range of ₹98 to ₹193. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (6 weeks and counting).
Today the stock is in a confirmed uptrend — week 28 of stage 2, confirmed. At ₹145 it trades +5.7% versus its 200-day average and sits at 50% of its 52-week range (₹98–₹193).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +124% while the NIFTY 500 moved +264% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-07-31) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Jammu and Kashmir Bank Ltd's story is not scored yet against the markers our research file set on 17 May 2026. Where it sits in its own cycle: LATE_CYCLE_TO_CONTRACTION.
Our read, 17 May 2026. Fourth consecutive record year — operating leverage delivered through cost cuts and credit outperformance, but PB at 83rd percentile in mid-contraction means the re-rating is fully priced.
From the numbers. PB at 0.87x — 83rd percentile, 1.8x median of 0.5x. Peaked at 1.2x in Mar 2024 after GNPA normalization re-rating from 0.3x. Now in MID_CONTRACTION. TTM PAT growth 0.47%. Cycle is fully expanded — the GNPA recovery play…
From the price. Price stage 2, week 28 — above its 200-day line, relative strength falling.
From the research. Fourth consecutive record year — operating leverage delivered through cost cuts and credit outperformance, but PB at 83rd percentile in mid-contraction means the re-rating is fully priced.
🚨 Where they disagree. PB at 0.87x — 83rd percentile, 1.8x median of 0.5x. Peaked at 1.2x in Mar 2024 after GNPA normalization re-rating from 0.3x. Now in MID_CONTRACTION. TTM PAT growth 0.47%. Cycle is fully expanded — the GNPA recovery play is priced in. FII buying is noted (shareholding rose from 2.24% Mar 2023 to 7.85% Sep 2025) but doesn't override the cycle valuation signal at 83rd percentile.
What is proven. Fourth consecutive record year — operating leverage delivered through cost cuts and credit outperformance, but PB at 83rd percentile in mid-contraction means the re-rating is fully priced.
What is not proven yet. PB at 1.8x median (83rd percentile) in MID_CONTRACTION after peaking 1.2x Mar 2024; re-rating catalyst fully priced in; at 0.6x PB (median territory) stock would trade at Rs 90 vs current Rs 131.
The test written in advance. PB MID_CONTRACTION — multiple compression toward 0.5x median — PB MID_CONTRACTION — multiple compression toward 0.5x median Quarterly PB trajectory — if crosses below 0.7x, median reversion thesis accelerating by the next result.
The test written in advance. QIP Dilution at Depressed PB — QIP Dilution at Depressed PB QIP pricing and timeline — if completed at PB >0.9x, dilution contained by the next result.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Employee Cost Structural Decline | MEDIUM_HIGH | — | High-cost retirees (pension NPS migration) replaced at lower cost — FY26 cost fell 11% YoY to Rs 2,500 Cr; FY27 guided below Rs… | Quarterly PB trajectory — if crosses below 0.7x, median reversion thesis accelerating |
| Credit Growth Outperformance (ROI… | MEDIUM | — | Advances +16.8% vs system 11.7%; ROI advances +28.8% vs J&K 9.5%; medium-term 50-50 target reduces single-geography concentration. | Quarterly PB trajectory — if crosses below 0.7x, median reversion thesis accelerating |
| Asset Quality — GNPA Normalization… | LOW | — | GNPA 2.50%, NNPA 0.64%, PCR >90%, zero credit cost, SMA total from 22.33% to 12.07% — sixth consecutive year of improvement.… | Quarterly PB trajectory — if crosses below 0.7x, median reversion thesis accelerating |
The dot is where the company is now; the dashed line is the level that would settle the question; a tinted band is where management says it is heading.
Lever 12 · New product launch — BUILDING. High-cost retirees (pension NPS migration) replaced at lower cost — FY26 cost fell 11% YoY to Rs 2,500 Cr; FY27 guided below Rs 2,500 Cr, perpetuating operating leverage. What proves it keeps working: Employee Cost Structural Decline. It stops working if Quarterly PB trajectory — if crosses below 0.7x, median reversion thesis accelerating.
Lever 5 · Regulatory approval — BUILDING. Advances +16.8% vs system 11.7%; ROI advances +28.8% vs J&K 9.5%; medium-term 50-50 target reduces single-geography concentration. What proves it keeps working: Credit Growth Outperformance (ROI Diversification). It stops working if Quarterly PB trajectory — if crosses below 0.7x, median reversion thesis accelerating.
Lever 7 · Consolidation — BUILDING. GNPA 2.50%, NNPA 0.64%, PCR >90%, zero credit cost, SMA total from 22.33% to 12.07% — sixth consecutive year of improvement. Re-rating catalyst fully executed. What proves it keeps working: Asset Quality — GNPA Normalization (PRICED-IN). It stops working if Quarterly PB trajectory — if crosses below 0.7x, median reversion thesis accelerating.
Sources: our stock research file (17 May 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
Jammu and Kashmir Bank Ltd reported ₹3,547 Cr of income in the Jun 26 quarter, +8.5% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 6.7% a year. The last full year, FY26, came in at ₹13,151 Cr. The last four reported quarters add to ₹13,428 Cr.
Why this happened. Employee cost declined 11% YoY to Rs 2,500 Cr in FY26. Q4 included Rs 153 Cr actuarial reversal on retirement benefit discount change but ex-reversal the underlying structural trajectory remains negative. FY27 guided below Rs 2,500 Cr (~Rs 500 Cr quarterly in first 2 quarters) despite selective talent hiring. Business per employee +17%, net profit per employee +17%. This is the most durable operating leverage lever for the bank in the near term.
FY26 revenue came in at ₹13,151 Cr (+4.9% on the year), capping 10 years at 6.7% compound. The latest quarter (Jun 26) printed ₹3,547 Cr, +8.5% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +4.8% growth against the decade's 6.7% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +4.8% over the last 4 quarters against +7.8%/yr over the last 8 — stabilising; TTM profit +7.2% vs +11.4%/yr — rolling over.
FY26-Q4. revenue ₹3,273 Cr and profit ₹799 Cr as reported.
FY27-Q1. revenue ₹3,547 Cr and profit ₹429 Cr as reported.
Why-sources: our stock research file (17 May 2026) and the company’s own results for those quarters.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
Jammu and Kashmir Bank Ltd's net margin is 12.1% in the Jun 26 quarter, −2.7 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the net margin has ranged −24.4% to 17.9%. The current quarter sits inside that band.
The latest quarter's net margin is 12.1%, −2.7 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged −24.4%–17.9%, and FY26's 17.9% is the top of that band — a record year.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
FY26-Q4. revenue ₹3,273 Cr and profit ₹799 Cr as reported.
FY27-Q1. revenue ₹3,547 Cr and profit ₹429 Cr as reported.
Why-sources: our stock research file (17 May 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Jammu and Kashmir Bank Ltd earned ₹429 Cr of net profit in the Jun 26 quarter, −11.5% year on year. Full-year FY26 profit was ₹2,360 Cr. The 10-year compound rate is 19.0%. That is 12.1% of the quarter's revenue. The same quarter a year earlier earned ₹485 Cr.
Jun 26 profit was ₹429 Cr, −11.5% year on year. On the full year, FY26 printed ₹2,360 Cr (+13.4%), and the 10-year compound rate is 19.0%.
🚨 Why profit moved: revenue contributed +8.5% and the margin −2.7 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +6.3% vs revenue +4.8%. Profit and revenue are moving roughly in step.
FY26-Q4. revenue ₹3,273 Cr and profit ₹799 Cr as reported.
FY27-Q1. revenue ₹3,547 Cr and profit ₹429 Cr as reported.
Why-sources: our stock research file (17 May 2026) and the company’s own results for those quarters.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Jammu and Kashmir Bank Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Jammu and Kashmir Bank Ltd's revenue grew +4.9% in FY26 to ₹13,151 Cr, so the book is growing. The latest quarter ran +8.5% year on year. The net margin on that income is 12.1%, −2.7 percentage points against a year ago.
FY26 revenue was ₹13,151 Cr, +4.9% on the year, and the latest quarter ran +8.5% year on year. The net margin on that revenue is 12.1% this quarter (−2.7 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Jammu and Kashmir Bank Ltd earns a return on equity of 15% in FY26. Its trough over the ladder below was −27% in FY17. On the asset side every ₹100 of the balance sheet earned about ₹1.25, which is the return before leverage is applied.
FY26 ROE came in at 15%, recovered from a FY17 trough of −27%. On assets, the latest reading is about 1.25% — every ₹100 the bank deploys earns roughly ₹1.25 a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded 19.0% a year over 10 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions added 2.2 points of Jammu and Kashmir Bank Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 9.4% of the company. Domestic institutions moved +1.1 points over the same window, to 7.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: +2.2 points over 8 quarters to 9.4%; Domestic institutions: +1.1 points over 8 quarters to 7.8%; Promoters: +0.0 points over 8 quarters to 59.4%.
Why the register moved: foreign institutions drove it (+2.2 points), alongside domestic institutions (+1.1 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Jammu and Kashmir Bank Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
Why this happened. J&K Bank systematically grew the Rest-of-India book from 37% of advances to drive diversification. Personal loans ROI +13% YoY, car loans +17.5%, agriculture +27.6%, corporate +38.5%. CD ratio reached 72% (guided 70%). RIDF maturities of ~Rs 3,000 Cr annually redeployable into higher-yield credit. Co-lending program started Q4 FY26 with FY27 target Rs 1,000 Cr and board approval up to Rs 5,000 Cr.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Jammu and Kashmir Bank Ltd trades at 0.9× P/BV, at the pricey end of its own range (85th percentile). Its long-run median P/BV is 0.5×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 0.9× is at the pricey end of its own range (85th percentile), against a long-run median of 0.5× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved +43.7% — the price ran ahead of the book, pushing the multiple up its own range.
The price move, decomposed: over 5y, of the +30.9%/yr price move, ~+11.3%/yr came from book-value growth and ~+19.6 pp from the multiple (expanding); over 10y, of the +6.3%/yr price move, ~+2.1%/yr came from book-value growth and ~+4.2 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the book-value line underneath it, not the multiple.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Jammu and Kashmir Bank Ltd was paying for profit growth of about −0.1% a year. Profit itself has compounded 19.0% a year over the past 10 years. Today the market pays 0.9× P/BV, the 85th percentile of its own 11-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is below what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Jammu and Kashmir Bank Ltd reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 14.3% and holding. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +4.9% | +12.0% | +10.1% | +6.7% |
| Profit | +13.4% | +26.0% | +40.7% | +19.0% |
| EPS | +13.3% | +23.3% | +29.0% | +9.6% |
| Share price | +43.7% | +12.8% | +30.9% | +6.3% |
4-Factor Sector Score
53.4/100 — rank 7 of 18 in Banks - Private · 88% evidence confidence
Jammu and Kashmir Bank Ltd scores 53.4 out of 100 against the 18 companies it is compared with in Banks - Private, ranking 7. Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
The four contributions add to the total exactly: 12.8 + 16.2 + 14.9 + 9.5 = 53.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Said versus delivered
What Jammu and Kashmir Bank Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
🚨 Employee Cost Run-Rate Miss · 29 July 2026. Management's May 2026 forecast implied an employee-cost run rate of about INR500 crores or lower for Q1 and Q2, while Jul 2026 reports Q1 employee cost of INR650 crores and calls Q1 the base for the year. The latest call cites the prior-quarter reversal and INR150 crores of pension, gratuity, and leave provisions, but does not reconcile why the previously anticipated run rate was missed or establish whether the higher base is temporary.
Capital Raise Quantum Increased Without Rationale · 29 July 2026. In May 2026, management described INR1,250 crores as the planned current-year capital raise with Board and shareholder approval already obtained. In Jul 2026, management said the quantum would be revised upward and that the government might dilute, but did not explain the larger capital requirement or the changed participation assumptions.
ROA Guidance Numerically Softened · 29 July 2026. May 2026 gave an explicit FY27 ROA objective of maintaining 1.37%. Although Jul 2026 said the guidance was unchanged, management separately stated a lower and less precise formulation of 1.25% plus; the reference to being around last year's level does not explain why the previously explicit target was replaced.
🚨 Capital Raise Timeline Deferred and Rationale Shifted · 5 May 2026. In the Jan 2026 call, the CFO targeted QIP completion by March 31, 2026, framing the raise as necessary to support credit growth in J&K infrastructure development. The May 2026 call makes no mention of any completed equity raise and instead defers INR1,250 crores of capital raising to FY27 at an opportune time, with the rationale reframed around ECL implementation due April 2027, leaving the missed March 2026 target entirely unaddressed.
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Tamilnad Mercantile Bank LtdTMB | 75.3/100Favorable setup100% evidence | LEADER | 23.3/35 Income 12.9% · PAT 20.5% 100% evidence | 22.6/25 ROA 2% · ROE 14% · GNPA 0.7% 100% evidence | 11.5/20 P/BV 1.37× · P/BV÷ROE 0.1 100% evidence | 17.9/20 RS sector 24.1% · RS bench 42.6% · 1Y 114.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 22.6 + 11.5 + 17.9 = 75.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Karur Vysya Bank LtdKARURVYSYA | 74.0/100Favorable setup100% evidence | BREAKING OUT | 27.2/35 Income 16% · PAT 37% 100% evidence | 22.9/25 ROA 1.8% · ROE 19.1% · GNPA 0.7% 100% evidence | 7.8/20 P/BV 2.29× · P/BV÷ROE 0.12 100% evidence | 16.1/20 RS sector 2.6% · RS bench 19% · 1Y 62%10 of 12 weeks ahead 100% evidence |
| Exact sum: 27.2 + 22.9 + 7.8 + 16.1 = 74 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3DCB Bank LtdDCBBANK | 69.3/100Favorable setup100% evidence | TURNING | 22.8/35 Income 11.5% · PAT 23.1% 100% evidence | 11.4/25 ROA 0.8% · ROE 12% · GNPA 2.4% 100% evidence | 16.2/20 P/BV 1.11× · P/BV÷ROE 0.09 100% evidence | 18.9/20 RS sector 10.7% · RS bench 28.6% · 1Y 81.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 11.4 + 16.2 + 18.9 = 69.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4City Union Bank LtdCUB | 64.7/100Mixed-positive evidence100% evidence | BREAKING OUT | 24.7/35 Income 19.8% · PAT 20.5% 100% evidence | 16.6/25 ROA 1.4% · ROE 13.2% · GNPA 1.7% 100% evidence | 10.3/20 P/BV 2.12× · P/BV÷ROE 0.16 100% evidence | 13.1/20 RS sector -0.8% · RS bench 15.6% · 1Y 51.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 24.7 + 16.6 + 10.3 + 13.1 = 64.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 5Karnataka Bank LtdKTKBANK | 60.3/100Mixed-positive evidence100% evidence | LEADER | 16.5/35 Income 0.5% · PAT 23.4% 100% evidence | 10.7/25 ROA 1% · ROE 10.4% · GNPA 2.6% 100% evidence | 13.9/20 P/BV 0.93× · P/BV÷ROE 0.09 100% evidence | 19.2/20 RS sector 22.5% · RS bench 41.1% · 1Y 86.8%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.5 + 10.7 + 13.9 + 19.2 = 60.3 · Decision use: Price leads the evidence: RS versus the benchmark is 41.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6South Indian Bank LtdSOUTHBANK | 59.0/100Mixed-positive evidence93% evidence | FADING | 21.9/35 Income 6.9% · PAT 13.5% 100% evidence | 13.4/25 ROA 1.2% · ROE 13.5% · GNPA — 72% evidence | 15.0/20 P/BV 1.02× · P/BV÷ROE 0.08 100% evidence | 8.7/20 RS sector -0.7% · RS bench 15.3% · 1Y 61.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 21.9 + 13.4 + 15 + 8.7 = 59 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Jammu and Kashmir Bank Ltdthis pageJ&KBANK | 53.4/100Mixed-positive evidence88% evidence | FADING | 12.8/35 Income 4.8% · PAT 7.2% 86% evidence | 16.2/25 ROA 1.3% · ROE 15.4% · GNPA — 72% evidence | 14.9/20 P/BV 0.94× · P/BV÷ROE 0.06 100% evidence | 9.5/20 RS sector 0.9% · RS bench 16.4% · 1Y 43.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 16.2 + 14.9 + 9.5 = 53.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 8RBL Bank LtdRBLBANK | 51.0/100Mixed-positive evidence88% evidence | LEADER | 23.3/35 Income 5.4% · PAT 54.8% 86% evidence | 6.6/25 ROA 0.5% · ROE 5.4% · GNPA — 72% evidence | 4.4/20 P/BV 1.52× · P/BV÷ROE 0.28 100% evidence | 16.7/20 RS sector 8.8% · RS bench 26.4% · 1Y 49.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 6.6 + 4.4 + 16.7 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Yes Bank LtdYESBANK | 49.5/100Mixed-negative evidence100% evidence | TURNING | 22.6/35 Income -0.5% · PAT 37.8% 100% evidence | 12.2/25 ROA 1% · ROE 7.1% · GNPA 1.3% 100% evidence | 7.6/20 P/BV 1.41× · P/BV÷ROE 0.2 100% evidence | 7.1/20 RS sector -7.5% · RS bench 8.3% · 1Y 14.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 22.6 + 12.2 + 7.6 + 7.1 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Dhanlaxmi Bank LtdDHANBANK | 49.2/100Mixed-negative evidence97% evidence | ASLEEP | 25.8/35 Income 21.7% · PAT 32.2% 95% evidence | 8.0/25 ROA 0.5% · ROE 7.2% · GNPA 1.8% 95% evidence | 7.9/20 P/BV 0.81× · P/BV÷ROE 0.11 100% evidence | 7.5/20 RS sector -2.9% · RS bench 12.7% · 1Y 24.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 25.8 + 8 + 7.9 + 7.5 = 49.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Federal Bank LtdFEDERALBNK | 48.7/100Mixed-negative evidence75% evidence | LEADER | 16.1/35 Income 6.5% · PAT 17% 76% evidence | 12.8/25 ROA — · ROE 11.6% · GNPA — 34% evidence | 6.3/20 P/BV 2.12× · P/BV÷ROE 0.18 100% evidence | 13.5/20 RS sector 6% · RS bench 22.6% · 1Y 80.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 12.8 + 6.3 + 13.5 = 48.7 · Decision use: Price leads the evidence: RS versus the benchmark is 22.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 12ICICI Bank LtdICICIBANK | 47.8/100Mixed-negative evidence79% evidence | FADING | 10.6/35 Income 4% · PAT 5.7% 62% evidence | 19.9/25 ROA 2.1% · ROE 15.9% · GNPA — 68% evidence | 9.9/20 P/BV 2.62× · P/BV÷ROE 0.17 100% evidence | 7.4/20 RS sector -12.2% · RS bench 2.9% · 1Y -1.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 10.6 + 19.9 + 9.9 + 7.4 = 47.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13HDFC Bank LtdHDFCBANK | 47.3/100Mixed-negative evidence84% evidence | BASING | 13.1/35 Income 2.8% · PAT 12.5% 76% evidence | 17.2/25 ROA 1.8% · ROE 13.6% · GNPA — 68% evidence | 14.4/20 P/BV 1.82× · P/BV÷ROE 0.13 100% evidence | 2.6/20 RS sector -29.5% · RS bench -16.5% · 1Y -26.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 17.2 + 14.4 + 2.6 = 47.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 14IDFC First Bank LtdIDFCFIRSTB | 42.5/100Mixed-negative evidence82% evidence | BREAKING OUT | 26.4/35 Income 12.3% · PAT 77.3% 86% evidence | 6.0/25 ROA 0.5% · ROE 3.8% · GNPA — 72% evidence | 3.5/20 P/BV 1.53× · P/BV÷ROE 0.41 100% evidence | 6.6/20 RS sector -17.6% · RS bench 13.3% · 1Y 18.7%10 of 10 weeks ahead 70% evidence |
| Exact sum: 26.4 + 6 + 3.5 + 6.6 = 42.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17.6% and the one-year return is 18.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 15Kotak Mahindra Bank LtdKOTAKBANK | 41.9/100Mixed-negative evidence93% evidence | TURNING | 8.7/35 Income 5.7% · PAT 6% 100% evidence | 16.3/25 ROA 1.9% · ROE 11.4% · GNPA — 72% evidence | 7.8/20 P/BV 2.3× · P/BV÷ROE 0.2 100% evidence | 9.1/20 RS sector -10.8% · RS bench 4.8% · 1Y 7.7%4 of 12 weeks ahead 100% evidence |
| Exact sum: 8.7 + 16.3 + 7.8 + 9.1 = 41.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Axis Bank LtdAXISBANK | 37.8/100Mixed-negative evidence93% evidence | ASLEEP | 6.2/35 Income 5.6% · PAT -0.2% 100% evidence | 15.2/25 ROA 1.6% · ROE 13.1% · GNPA — 72% evidence | 14.1/20 P/BV 1.75× · P/BV÷ROE 0.13 100% evidence | 2.3/20 RS sector -15.2% · RS bench -0.8% · 1Y 18%1 of 12 weeks ahead 100% evidence |
| Exact sum: 6.2 + 15.2 + 14.1 + 2.3 = 37.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 17IndusInd Bank LtdINDUSINDBK | 27.1/100Adverse evidence100% evidence | LEADER | 12.5/35 Income -6.4% · PAT 31.1% 100% evidence | 2.3/25 ROA 0.2% · ROE 1.4% · GNPA 3.3% 100% evidence | 3.2/20 P/BV 1.16× · P/BV÷ROE 0.85 100% evidence | 9.1/20 RS sector -4.3% · RS bench 11.3% · 1Y 29.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 12.5 + 2.3 + 3.2 + 9.1 = 27.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Bandhan Bank LtdBANDHANBNK | 24.6/100Adverse evidence100% evidence | ASLEEP | 8.7/35 Income -0.2% · PAT -34% 100% evidence | 5.5/25 ROA 0.6% · ROE 4.9% · GNPA 3.1% 100% evidence | 6.2/20 P/BV 1.11× · P/BV÷ROE 0.23 100% evidence | 4.2/20 RS sector -10.4% · RS bench 4.2% · 1Y 8.1%4 of 12 weeks ahead 100% evidence |
| Exact sum: 8.7 + 5.5 + 6.2 + 4.2 = 24.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Jammu and Kashmir Bank Ltd's share price today?
Jammu and Kashmir Bank Ltd trades at ₹145, +43.7% over the past year. The company is valued at ₹15,997 Cr. The stock sits at 50% of its 52-week range of ₹98–₹193, +5.7% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 28 weeks in. — as of 11 September 2026.
What were Jammu and Kashmir Bank Ltd's latest quarterly results?
Jammu and Kashmir Bank Ltd reported total income of ₹3,547 Cr and net profit of ₹429 Cr for the Jun 26 quarter. Income rose 8.5% and profit fell 11.5% year on year. Earnings per share were ₹3.89. The net margin was 12.1%, 2.7 pp lower than a year earlier. — as of 11 September 2026.
What is Jammu and Kashmir Bank Ltd's revenue?
Jammu and Kashmir Bank Ltd reported revenue of ₹3,547 Cr in the Jun 26 quarter, +8.5% year on year. For the full FY26 fiscal year, revenue was ₹13,151 Cr (+4.9%). Over the last 10 years revenue compounded at 6.7% a year. — as of 11 September 2026.
What is Jammu and Kashmir Bank Ltd's profit?
Jammu and Kashmir Bank Ltd earned ₹429 Cr of net profit in the Jun 26 quarter, −11.5% year on year. Full-year FY26 profit was ₹2,360 Cr. The net margin ran 12.1% in the latest quarter. — as of 11 September 2026.
What is Jammu and Kashmir Bank Ltd's market cap?
Jammu and Kashmir Bank Ltd's market capitalisation is ₹15,997 Cr at a share price of ₹145. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Jammu and Kashmir Bank Ltd's P/BV ratio?
Jammu and Kashmir Bank Ltd trades at a P/BV of 0.9×, at the 85th percentile of its own 11-year range, against a long-run median of 0.5×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Jammu and Kashmir Bank Ltd pay a dividend?
Not in its latest year — Jammu and Kashmir Bank Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 6 of its last 13 reported fiscal years, so there is a history but no current dividend. — as of 11 September 2026.
Is Jammu and Kashmir Bank Ltd overvalued?
On its own history, Jammu and Kashmir Bank Ltd looks expensive: its P/BV of 0.9× sits at the 85th percentile of its 11-year range (long-run median 0.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: the net margin is the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 11 September 2026.
Is Jammu and Kashmir Bank Ltd growing?
Not right now — Jammu and Kashmir Bank Ltd's latest numbers are shrinking: latest-quarter revenue +8.5% year on year, profit −11.5%, and the net margin −2.7 pp at 12.1%. The 10-year compound rates are 6.7% (revenue) and 19.0% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Jammu and Kashmir Bank Ltd performing?
Jammu and Kashmir Bank Ltd is in a confirmed uptrend, 28 weeks in. Its latest quarter's income rose 8.5% and profit fell 11.5% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Jammu and Kashmir Bank Ltd in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 14.3% and holding. The read comes from the last 12 quarters of growth (revenue growth +4.8% latest, profit growth +7.2% latest, eps growth +7.2% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Jammu and Kashmir Bank Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 28 of stage 2), trading +5.7% versus its 200-day average and at 50% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Jammu and Kashmir Bank Ltd beating the market?
Not lately — on a trailing-13-week view Jammu and Kashmir Bank Ltd is currently behind the NIFTY 500 (6 weeks and counting; last ahead the week of 2026-07-31), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +124% against the NIFTY 500's +264% — behind the index over the full window. — as of 11 September 2026.
Will Jammu and Kashmir Bank Ltd's share price go up?
This page publishes no price forecast for Jammu and Kashmir Bank Ltd. What it measures instead: the share price is ₹145, the price is in a confirmed uptrend 28 weeks in. Its P/BV of 0.9× sits at the 85th percentile of its own 11-year range. — as of 11 September 2026.
Who owns Jammu and Kashmir Bank Ltd?
Promoters hold 59.4% of Jammu and Kashmir Bank Ltd, foreign institutions 9.4%, domestic institutions 7.8% and the public 23.4% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 2.2 points over 8 quarters. — as of 11 September 2026.
Where is Jammu and Kashmir Bank Ltd in its business cycle?
Jammu and Kashmir Bank Ltd's FY26 net margin was 17.9%, against a 13-year band of −24.4%–17.9%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 12.1%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Jammu and Kashmir Bank Ltd's price assume?
At its price on 13 June 2026, Jammu and Kashmir Bank Ltd was priced for profit growth of about −0.1% a year. Profit itself has compounded 19.0% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Jammu and Kashmir Bank Ltd story?
The sharpest disagreement: the price moved +43.7% in a year while annual EPS moved +13.3% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Jammu and Kashmir Bank Ltd a stock worth studying right now?
This is not investment advice. The machine read: Jammu and Kashmir Bank Ltd's price has outrun its earnings. +43.7% in a year against EPS +13.3% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!